EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Fatal complication unveiled: analyzing intracerebral hemorrhage risk after CAR-T therapy in hematologic malignancies

Sijia Yan, Xi Ming, Jiaying Wu, Xiaojian Zhu, Mi Zhou, Yi Xiao

Brain Hemorrhages · 2025-10 · 6 (5) · 212-219

DOI: 10.1016/j.hest.2025.07.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Hemorrhages, 2025-10. Verfasst von Sijia Yan und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor T (CAR-T) cell therapy has demonstrated significant efficacy in the treatment of hematologic malignancies, yet it can lead to severe complications. Intracranial hemorrhage (ICH), although rare, is a particularly lethal outcome. Current research on the risk factors and underlying mechanisms of ICH post-CAR-T therapy remains limited. This retrospective study analyzed 10 cases of ICH among 2255 patients who underwent CAR-T therapy at Tongji Hospital in Wuhan from January 2015 to December 2024. We collected data on baseline characteristics, CAR-T treatment parameters, inflammatory markers, coagulation function, and clinical outcomes. The incidence of ICH was 0.44 %, with the median time to onset being 25 days following infusion. All affected patients exhibited thrombocytopenia, and 80 % experienced coagulopathy. Levels of C-reactive protein and Interleukin-6 were significantly elevated before and after treatment. The mortality rate was 90 %, with nine patients succumbing to respiratory and circulatory failure associated with ICH. The development of ICH after CAR-T therapy is strongly linked to thrombocytopenia, coagulopathy, and the inflammatory response triggered by cytokine release syndrome (CRS). Early identification and proactive management of high-risk patients could potentially improve outcomes. Further prospective studies are necessary to confirm risk prediction models and enhance therapeutic strategies.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yan, S., Ming, X., Wu, J., Zhu, X., Zhou, M., & Xiao, Y. (2025). Fatal complication unveiled: analyzing intracerebral hemorrhage risk after CAR-T therapy in hematologic malignancies. Brain Hemorrhages, 6(5), 212-219. https://doi.org/10.1016/j.hest.2025.07.007

Vancouver

Yan S, Ming X, Wu J, Zhu X, Zhou M, Xiao Y. Fatal complication unveiled: analyzing intracerebral hemorrhage risk after CAR-T therapy in hematologic malignancies. Brain Hemorrhages. 2025;6(5):212-219. doi:10.1016/j.hest.2025.07.007

BibTeX
@article{Yan2025,
  author = {Yan, Sijia and Ming, Xi and Wu, Jiaying and Zhu, Xiaojian and Zhou, Mi and Xiao, Yi},
  title = {Fatal complication unveiled: analyzing intracerebral hemorrhage risk after CAR-T therapy in hematologic malignancies},
  journal = {Brain Hemorrhages},
  year = {2025},
  volume = {6},
  number = {5},
  pages = {212--219},
  doi = {10.1016/j.hest.2025.07.007}
}
Kostenlos starten →